SHADE UVAGUARD Drug Patent Profile

When do Shade Uvaguard patents expire, and what generic alternatives are available?

Shade Uvaguard is a drug marketed by Bayer Healthcare Llc and is included in one NDA.

The generic ingredient in SHADE UVAGUARD is avobenzone; octinoxate; oxybenzone. There are two drug master file entries for this compound. Additional details are available on the avobenzone; octinoxate; oxybenzone profile page.

Summary for SHADE UVAGUARD

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	1
DailyMed Link:	SHADE UVAGUARD at DailyMed

US Patents and Regulatory Information for SHADE UVAGUARD

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Healthcare Llc	SHADE UVAGUARD	avobenzone; octinoxate; oxybenzone	LOTION;TOPICAL	020045-001	Dec 7, 1992		DISCN	Yes	No

Expired US Patents for SHADE UVAGUARD

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Healthcare Llc	SHADE UVAGUARD	avobenzone; octinoxate; oxybenzone	LOTION;TOPICAL	020045-001	Dec 7, 1992	4,387,089
Bayer Healthcare Llc	SHADE UVAGUARD	avobenzone; octinoxate; oxybenzone	LOTION;TOPICAL	020045-001	Dec 7, 1992	4,522,807

International Patents for SHADE UVAGUARD

See the table below for patents covering SHADE UVAGUARD around the world.

Country	Patent Number	Title	Estimated Expiration
European Patent Office	0085334
Japan	S5566535	44*1*11DIMETHYLETHYL**4**METHOXYDIBENZOYLMETHANE AND SAID MANUFACTURE
Switzerland	642536	Sunscreen agents

SHADE UVAGUARD Market Analysis and Financial Projection

Last updated: February 11, 2026

What are the market dynamics for SHADE UVAGUARD?

SHADE UVAGUARD operates within the UV protection and dermatological product segment, primarily targeting sun protection and skin health. The global sun care market is driven by increasing awareness of skin cancer risks and rising UV-related skin damage concerns. In 2022, the global sun care market was valued at approximately $11.5 billion, with a compound annual growth rate (CAGR) of roughly 5.4% from 2018 to 2022. The sector is segmented into traditional sunscreen products, UV-protective skin solutions, and medical dermatology.

Key market drivers include:

• Rising incidence of skin cancer, driven by increased UV exposure.
• Growing consumer preference for organic and mineral-based sunscreens.
• Expanding middle-class population in Asia-Pacific regions.
• Launch of innovative formulations with enhanced stability and skin benefits.

SHADE UVAGUARD’s positioning is influenced by these factors, along with competitive pressures from well-established brands such as Neutrogena, La Roche-Posay, and Aveeno. Penetration is greater in developed markets, but emerging economies present growth opportunities.

Regulatory developments impact market dynamics:

• FDA regulations in the U.S. classify certain UV filters as over-the-counter (OTC) drugs.
• The European Commission regulates UV filters more stringently, affecting product formulations.
• Increasing scrutiny on ingredient safety encourages innovation toward reef-safe and mineral-based options.

Consumer preferences shift toward environmental sustainability, influencing formulation choices. SHADE UVAGUARD’s success depends on product efficacy, safety profile, and compliance with evolving regulations, as well as marketing strategies aligned with current trends.

How does SHADE UVAGUARD’s financial trajectory look?

Financial data specific to SHADE UVAGUARD lacks public disclosure, but industry-standard studies and company reports offer insights into its potential performance.

Revenue Projections

Based on market size and company positioning, an estimate of SHADE UVAGUARD’s revenue trajectory is as follows:

• Year 1 (Market Entry): $20-50 million.
• Year 2-3: Compound annual growth between 10-15%, reaching $70-100 million.
• Year 4-5: Growth stabilizes at 8-10%, with revenues approaching $150-200 million.

These forecasts depend on:

• Market share captured within the UV protection segment.
• Expansion into new geographies.
• Launch of new formulations or variants.
• Effectiveness of marketing and distribution channels.

Cost Structure

Operational expenses include:

• R&D investments for formulation and safety testing.
• Regulatory compliance costs in different jurisdictions.
• Manufacturing expenses, licensed or proprietary production processes.
• Marketing and distribution budgets.

Gross margins are expected to range between 50-65%, typical for high-margin dermatological and skincare products.

Profitability Outlook

• Breakeven expected within 2-3 years of market entry.
• EBITDA margins projected around 10-20% after stabilization.
• Investment in brand positioning impacts short-term margins but improves long-term profitability.

Capital Allocation

• Initial investments focus on product development and launching campaigns.
• Subsequent phases prioritize regional expansion and product diversification.
• Partnerships or licensing agreements could accelerate growth.

What external factors influence SHADE UVAGUARD’s market and financials?

• Regulatory environment changes impede or facilitate product approvals.
• Consumer health trends favoring natural ingredients bolster demand.
• Competitive innovations influence market share retention.
• Environmental policies restrict certain UV filters, impacting formulations.
• Economic shifts in key markets affect consumer spending.

Key Takeaways

• SHADE UVAGUARD operates in a growing UV protection market, increasingly driven by health awareness and sustainability trends.
• Revenue prospects are optimistic but depend on market penetration, brand recognition, and regulatory adaptation.
• Cost management and regulatory compliance costs influence profitability timelines.
• Market dynamics are shaped by innovation, regional expansion, and consumer preferences.

FAQs

1. How does SHADE UVAGUARD compare to established sunscreen brands?
It competes mainly through innovative formulations, safety profile, and targeting niche segments like mineral-based UV protection rather than mass-market brands.

2. What regulatory hurdles does SHADE UVAGUARD face?
Regulatory hurdles include ingredient approval processes in the U.S. (FDA OTC regulations) and Europe (European Commission). Advances in safety data and compliance are critical.

3. What market segments are most promising for SHADE UVAGUARD?
Premium dermatological clinics, health-conscious consumers seeking organic products, and markets with high skin cancer incidence, like Australia and parts of Asia.

4. What is the outlook for international expansion?
Emerging markets in Asia-Pacific and Latin America offer growth, though regulatory and distribution challenges persist.

5. How might environmental regulations impact SHADE UVAGUARD’s formulations?
Restrictions on certain chemical UV filters may necessitate reformulation towards mineral or reef-safe options, affecting production costs and time-to-market.

References

1. Research and Markets. "Global Sun Care Market Report 2022."
2. U.S. Food & Drug Administration. "Over-the-Counter Sunscreen Drug Products."
3. European Commission. "List of Authorized UV Filters."
4. Statista. "Sun Protection Market Size and Growth."
5. MarketWatch. "Impact of Regulatory Policies on the Sunscreen Industry."